Although some studies mention the use of pioglitazone in the treatment of DN, comparing it with an α-adrenergic blocker (for which there is practically no information on its therapeutic effect in DN) and a DPP4 inhibitor remains a partially unexplored field. Here, DPP4 is linked to liver dysplastic nodule.